Sanofi India Board Meeting on Oct 29 to Approve Q3 FY27 Results, Dividend

Sanofi India Ltd has announced that its Board of Directors will convene on October 29, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the quarter and nine-months ended September 30, 2026. Additionally, the board will consider and approve any interim dividend for the financial year 2026. The trading window for company insiders will remain closed from October 1, 2026, until 48 hours after the results announcement.